Disco Pharmaceuticals is taking to the biotech dance floor with seed funding from major players and pipeline programs in small cell lung cancer and colorectal cancer.
Full story: https://www.biospace.com/article/abbvie-backed-disco-launches-with-20-m-in-funding-targets-oncology/